Teladoc Health (NYSE:TDOC) Sets New 12-Month Low – Here’s What Happened

Shares of Teladoc Health, Inc. (NYSE:TDOC) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $4.62 and last traded at $4.5950, with a volume of 1341115 shares changing hands. The stock had previously closed at $4.85.

Analyst Ratings Changes

Several research firms recently issued reports on TDOC. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a report on Monday, December 29th. Barclays began coverage on shares of Teladoc Health in a research note on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 target price for the company. Bank of America decreased their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 25th. Evercore cut their price objective on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday, October 30th. Finally, Citigroup reduced their target price on shares of Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Friday, January 9th. Three equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $9.12.

Teladoc Health Trading Down 6.3%

The company has a 50 day moving average of $6.70 and a 200 day moving average of $7.42. The firm has a market cap of $806.60 million, a price-to-earnings ratio of -3.57 and a beta of 2.12. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71.

Insider Activity

In other Teladoc Health news, insider Fernando M. Rodrigues sold 4,209 shares of the business’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Adam C. Vandervoort sold 5,720 shares of the company’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total transaction of $42,842.80. Following the sale, the insider directly owned 80,732 shares in the company, valued at $604,682.68. This represents a 6.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 33,288 shares of company stock worth $251,684. Company insiders own 0.58% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Large investors have recently modified their holdings of the stock. Allianz Asset Management GmbH boosted its stake in Teladoc Health by 189.2% in the 3rd quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock worth $12,518,000 after purchasing an additional 1,059,458 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in shares of Teladoc Health in the second quarter worth about $2,722,000. Wealth Management Associates Inc. bought a new position in shares of Teladoc Health in the second quarter valued at approximately $509,000. Banco Bilbao Vizcaya Argentaria S.A. boosted its position in shares of Teladoc Health by 23.1% in the second quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 212,933 shares of the health services provider’s stock valued at $1,841,000 after acquiring an additional 39,956 shares during the period. Finally, Empowered Funds LLC purchased a new position in Teladoc Health during the second quarter valued at approximately $5,040,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.